IMC Intrinsic Valuation and Fundamental Analysis - Immuron Ltd

Watchlist Manager

Watchlist

Price: 0.038 AUD -9.52% Market Closed

Market Cap: AU$12.3m

	Immuron Ltd ASX:IMC	AU
	FOS Capital Ltd ASX:FOS	AU
	Diablo Resources Ltd OTC:DBORF	AU
L	Lohakit Metal PCL SET:LHK	TH
M	Mitsubishi Heavy Industries Ltd DUS:MIH	JP
	Alan Allman Associates SA PAR:AAA	FR
E	Eurazeo SE DUS:EUQ	FR
	Metalpha Technology Holding Ltd NASDAQ:MATH	HK
S	Sandfire Resources Ltd F:S2Z	AU
	Barry Callebaut AG F:BCLN	CH

Intrinsic Value

IMC doesn't have a meaningful market cap.

Is IMC undervalued or overvalued?

See the intrinsic value estimate for Immuron Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

IMC Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with IMC’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Margin of Safety 20% Locked

Current Price AU$0.04

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Immuron Does

Biotechnology Health Care

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada.

Headquarters: Australia AU
Employees: 7
IPO date: Apr 30, 1999